Jun Liu
Director/Miembro de la Junta en CHANGZHOU QIANHONG BIOPHARMA CO.,LTD .
Fortuna: 18 M $ al 30/04/2024
Perfil
Jun Liu is currently a Director at Changzhou Qianhong Biopharma Co., Ltd., Zonhon Biopharma Institute, Inc., and Aucentra Therapeutics Pty Ltd.
He previously worked as a Director-Supervisory Board at Changzhou Bio-pharma Qianhong Co. Ltd.
and as a Member at Jiangsu Biological Technology Association.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 30/09/2022 | 18 044 733 ( 5.04% ) | 13 M $ | 30/04/2024 | |
| 30/09/2022 | 6 014 911 ( 0.65% ) | 4 M $ | 30/04/2024 |
Cargos activos de Jun Liu
| Empresas | Cargo | Inicio |
|---|---|---|
| CHANGZHOU QIANHONG BIOPHARMA CO.,LTD | Director/Miembro de la Junta | 15/05/2015 |
| Zonhon Biopharma Institute, Inc. | Director/Miembro de la Junta | 09/02/2015 |
Aucentra Therapeutics Pty Ltd.
 Aucentra Therapeutics Pty Ltd. BiotechnologyHealth Technology Aucentra Therapeutics Pty Ltd. is an Australian biotech company that develops advanced anti-cancer drugs. The private company is based in Adelaide, Australia. Established in 2017, the company focuses on breakthrough classes of drugs to address unmet medical needs for some of the most severe cancers, including leukaemia, breast cancer, colorectal cancer, glioblastoma, lung cancer, prostate cancer, and ovarian cancer. The company's pipeline consists of first-in-class or novel kinase inhibitors in pre-clinical and clinical stage development, with a particular focus on targeting cyclin dependent kinases (cdks), known for their over-expression in cancer cells. The company was founded in 2017 by Shudong Wang, and the CEO is Joe Bayer. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Jun Liu.
| Empresas | Cargo | Fin |
|---|---|---|
| Changzhou Bio-pharma Qianhong Co. Ltd. | Director/Miembro de la Junta | - |
| Jiangsu Biological Technology Association | Corporate Officer/Principal | - |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| CHANGZHOU QIANHONG BIOPHARMA CO.,LTD | Health Technology |
| Empresas privadas | 4 |
|---|---|
| Jiangsu Biological Technology Association | |
| Changzhou Bio-pharma Qianhong Co. Ltd. | |
| Zonhon Biopharma Institute, Inc. | |
Aucentra Therapeutics Pty Ltd.
Aucentra Therapeutics Pty Ltd. BiotechnologyHealth Technology Aucentra Therapeutics Pty Ltd. is an Australian biotech company that develops advanced anti-cancer drugs. The private company is based in Adelaide, Australia. Established in 2017, the company focuses on breakthrough classes of drugs to address unmet medical needs for some of the most severe cancers, including leukaemia, breast cancer, colorectal cancer, glioblastoma, lung cancer, prostate cancer, and ovarian cancer. The company's pipeline consists of first-in-class or novel kinase inhibitors in pre-clinical and clinical stage development, with a particular focus on targeting cyclin dependent kinases (cdks), known for their over-expression in cancer cells. The company was founded in 2017 by Shudong Wang, and the CEO is Joe Bayer. | Health Technology |
- Bolsa de valores
- Insiders
- Jun Liu